Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Michael Glodé

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The Journal of Urology|November 7, 2006
The case for adjuvant therapy for prostate cancerL Michael Glodé
Expert Opinion on Pharmacotherapy|October 22, 2008
Management of the side effects of androgen deprivation therapy in men with prostate cancerThomas W Flaig, L Michael Glodé
Hematology/Oncology Clinics of North America|November 6, 2013
Neoadjuvant and adjuvant hormonal and chemotherapy for prostate cancerElaine T Lam, L Michael Glodé
Journal of Oncology Practice|September 4, 2012
Trends in twitter use by physicians at the american society of clinical oncology annual meeting, 2010 and 2011Aafia Chaudhry, L Michael Glodé, Matt Gillman, et al.
Urologic Oncology|July 29, 2011
Low-dose diethylstilbestrol for the treatment of advanced prostate cancerJulia Clemons, L Michael Glodé, Dexiang Gao, et al.
Ultrasonics|December 19, 2006
The effect of ultrasonic irradiation on doxorubicin-induced cytotoxicity in three human bladder cancer cell linesCaroline Arthur, Thomas Flaig, Lih-Jen Su, et al.
The Journal of Urology|March 27, 2007
Conference report and review: current status of biomarkers potentially associated with prostate cancer outcomesThomas W Flaig, Steven K Nordeen, M Scott Lucia, et al.
BJU International|August 2, 2006
Trends and predictors of aggressive therapy for clinical locally advanced prostate carcinomaThomas D Denberg, L Michael Glodé, John F Steiner, et al.
Cancer|June 17, 2006
A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancerThomas W Flaig, Albaha Barqawi, Gary Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Randomization reveals unexpected acute leukemias in Southwest Oncology Group prostate cancer trialThomas W Flaig, Catherine M Tangen, Maha H A Hussain, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Journal of Urology|November 7, 2006
The case for adjuvant therapy for prostate cancerL Michael Glodé
Expert Opinion on Pharmacotherapy|October 22, 2008
Management of the side effects of androgen deprivation therapy in men with prostate cancerThomas W Flaig, L Michael Glodé
Hematology/Oncology Clinics of North America|November 6, 2013
Neoadjuvant and adjuvant hormonal and chemotherapy for prostate cancerElaine T Lam, L Michael Glodé
Journal of Oncology Practice|September 4, 2012
Trends in twitter use by physicians at the american society of clinical oncology annual meeting, 2010 and 2011Aafia Chaudhry, L Michael Glodé, Matt Gillman, et al.
Urologic Oncology|July 29, 2011
Low-dose diethylstilbestrol for the treatment of advanced prostate cancerJulia Clemons, L Michael Glodé, Dexiang Gao, et al.
Ultrasonics|December 19, 2006
The effect of ultrasonic irradiation on doxorubicin-induced cytotoxicity in three human bladder cancer cell linesCaroline Arthur, Thomas Flaig, Lih-Jen Su, et al.
The Journal of Urology|March 27, 2007
Conference report and review: current status of biomarkers potentially associated with prostate cancer outcomesThomas W Flaig, Steven K Nordeen, M Scott Lucia, et al.
BJU International|August 2, 2006
Trends and predictors of aggressive therapy for clinical locally advanced prostate carcinomaThomas D Denberg, L Michael Glodé, John F Steiner, et al.
Cancer|June 17, 2006
A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancerThomas W Flaig, Albaha Barqawi, Gary Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Randomization reveals unexpected acute leukemias in Southwest Oncology Group prostate cancer trialThomas W Flaig, Catherine M Tangen, Maha H A Hussain, et al.
Pageof 2